How many times should I follow up with a Sales VP (after a demo)?

Ask after you've given them a reason to want to help, not after the first coffee. Same day with the recap. A value bump 3 days later if they went quiet. After that, send a breakup note and archive it. A sales VP who wants it will answer a clean close more often than a fifth bump.

Should I offer a referral fee in the email?

Only if that's already how you work and it won't make them look mercenary. Many operators prefer a clean intro. If you do mention a fee, keep it secondary to why the intro helps the other person. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Should I include a recording in the demo follow-up?

If you recorded it and they agreed, yes, plus timestamps for the two parts they cared about. A raw 40-minute link with no map is homework. Add the three bullets they'd need to brief a colleague. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Is it okay to send this referral request on LinkedIn instead of email?

Yes if this sales VP is actually active there and the thread isn't about long attachments. Keep the LinkedIn version even shorter. Don't paste the full email. One context line and one question is plenty. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

What should I never say in a Pharmaceuticals referral request?

Don't use consumer-startup slang. It's a credibility leak. Telling them how to sell. They've heard it. Don't send a 19-page deck that relitigates features they skipped. Those three mistakes show up constantly in Pharmaceuticals inboxes and they all read as "this was templated."

Pharmaceuticals · Sales VP · After Demo

Referral Request for Pharmaceuticals Sales VP: After Demo

Use this referral request template when you're emailing a Sales VP in Pharmaceuticals (after a demo). They saw the product. Now they're comparing, forwarding, or quietly deciding it wasn't for them. Keep the note aligned with Crisp and commercial. They can handle a direct ask.

Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors

We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.

Sources: HubSpot sales email benchmarks; Gong follow-up research

Why does this referral request work for a Pharmaceuticals Sales VP?

Ask for a specific profile, not 'anyone in your network.'
Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
Fits how a sales VP actually reads: 70 to 90 words. Lead with the outcome.
Replay the two moments they leaned in, and the one concern they named.
Give them cover to decline.

When should I send this to a Pharmaceuticals Sales VP?

Ask after you've given them a reason to want to help, not after the first coffee. Same day with the recap. A value bump 3 days later if they went quiet. For this combo, treat "Same day, then 3 days if silent" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a sales VP, 70 to 90 words. Lead with the outcome.

What this Sales VP actually cares about

A sales VP in Pharmaceuticals is protecting quota, forecast credibility, and rep time. They think in pipeline, ramp, and forecast risk. If you can't map your email to a number they already report, it feels like a hobby. The hook that earns a look is a stage in the funnel that's leaking, a slow follow-up SLA, or a ramp problem. The ask should stay at this size: a 15-minute look at one metric, not a platform tour. Delete trigger: Telling them how to sell. They've heard it. They think in pipeline, ramp, and forecast risk. If you can't map your email to a number they already report, it feels like a hobby.

How Pharmaceuticals changes the note

Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. A thread that ignores follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick reads like every other vendor bump.

How should I customize this template before I send it?

Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
Keep the tone crisp and commercial.
Keep the ask to one person or one tightly defined role.
Time it for Same day, then 3 days if silent. Same day with the recap. A value bump 3 days later if they went quiet.
Don't use consumer-startup slang. It's a credibility leak.

What mistakes should I avoid with this after demo note?

Asking 'who do you know?' is lazy and gets no names.
Don't send a 19-page deck that relitigates features they skipped.
Don't use consumer-startup slang. It's a credibility leak.
Telling them how to sell. They've heard it.

How does this after demo scenario compare?

Dimension	For this template
Best send window	Same day, then 3 days if silent
Ideal length	70 to 90 words. Lead with the outcome.
Primary ask	a 15-minute look at one metric, not a platform tour
Industry metric to cite	time through MLR, access, and compliant engagement rates
Tone	Crisp and commercial. They can handle a direct ask.
Unlike after meeting	They have product context now. Speak to what they saw, not to a generic intro.
Unlike after proposal	Pricing may not be on paper yet. Don't jump to 'ready to sign.'

What should I copy and send?

Copy-ready template

Subject

Quick referral ask on [topic]

Body

Hi [First Name],

If you're willing, I wrote a blurb you can forward as-is.

I'm writing because a label update, a launch window, or a congress. Ideal person: [role] at a [company type] dealing with follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick. Not trying to spray this across your whole book.

Replay the two moments they leaned in, and the one concern they named.

If you want changes to the blurb, tell me and I'll rewrite it.

Best,
[Your Name]
[Your Title]
[Your Company]

Questions people ask before they hit send

Name the situation and the business object, not your excitement. Something like "Quick referral ask on [topic]" outperforms "Just checking in" because a sales VP can decide from the preview text whether it's worth opening. Keep it under 50 characters when you can.

Related templates

Want a custom draft instead? Try the email generator.